MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implicationsMuller Fabbri, George A. Calin, Michael Andreeff et al.|Leukemia|2008Cited by 145
MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung CancerFrancesca Fanini, Muller Fabbri|International Journal of Molecular Sciences|2021Cited by 13
Overexpression of ultraconserved region 83- induces lung cancer tumorigenesisIvan Vannini, Muller Fabbri|PLoS ONE|2022Cited by 8